China SXT Pharmaceuticals, Inc. (SXTC) Investment Research Dashboard
About China SXT Pharmaceuticals, Inc. (SXTC) stock analysis
Get live SXTC stock price $0.07, comprehensive China SXT Pharmaceuticals, Inc. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time SXTC stock data and investment insights.
Loading chart data...
China SXT Pharmaceuticals, Inc. (SXTC) Overview
China SXT Pharmaceuticals, Inc. (SXTC) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, SXTC trades at $0.07 with a market capitalization of 46.23K . Over the past 52 weeks, SXTC has traded between $0.05 and $1047.00 , with the current price positioned at approximately 0% of this...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 46.23K
- Current price: $0.07
- 52-week range: $0.05 - $1047.00
- P/E ratio: 0.02
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, an...
Company Information
- CEO
- Feng Zhou
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 56
Contact Information
- Website
- http://www.sxtchina.com
- Address
- 178 Taidong Road North
- Country
- CN
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Listed on major US exchange (NASDAQ) providing liquidity and transparency
✓ Valuation metrics suggest potential value opportunity (P/E: 0.0)
✓ Higher growth potential with elevated volatility (Beta: 1.82)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for China SXT Pharmaceuticals, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for China SXT Pharmaceuticals, Inc.
- ⚠Investors should consider how China SXT Pharmaceuticals, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
46.23K
P/E Ratio (TTM)
0.02
Beta
1.82
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare SXTC with peer companies:
- Price
- $0.90+0.00% (1D)
- Market cap
- 73.17M
- Price
- $8.16+0.37% (1D)
- Market cap
- 300.19M
- Price
- $8.28+22.30% (1D)
- Market cap
- 413.02M
- Price
- $2.43+0.62% (1D)
- Market cap
- 282.85M
- Price
- $1.81+1.83% (1D)
- Market cap
- 170.37M
- Price
- $3.00+1.69% (1D)
- Market cap
- 35.89M
- Price
- $1.13-2.59% (1D)
- Market cap
- 97.05M
- Price
- $19.33+0.13% (1D)
- Market cap
- 512.90M
- Price
- $1.32+8.20% (1D)
- Market cap
- 63.77M
- Price
- $10.29+4.45% (1D)
- Market cap
- 164.01M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
82/100 ⭐⭐⭐⭐⭐
- Overall
- +0.2%
- NYSE
- +0.1%
- NASDAQ
- +0.4%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | -0.3% | +0.9% | +1.6% | 19.2 | 82/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.2% | +2.7% | +1.5% | 23.6 | 82/100⭐⭐⭐⭐⭐ |
| Communication Services | +0.7% | -2.1% | +2.2% | 22.2 | 74/100⭐⭐⭐⭐⭐ |
| Consumer Defensive | +1.3% | +1.5% | +0.3% | 29.2 | 69/100⭐⭐⭐⭐ |
| Energy | +0.3% | +0.0% | -1.9% | 19.5 | 63/100⭐⭐⭐⭐ |
| Basic Materials | -1.0% | +0.1% | -2.1% | 24.8 | 51/100⭐⭐⭐ |
| Utilities | -1.4% | +1.8% | -2.6% | 25.3 | 48/100⭐⭐⭐ |
| Real Estate | -1.6% | +1.2% | -2.5% | 29.4 | 43/100⭐⭐⭐ |
| Consumer Cyclical | -0.3% | -2.2% | -4.6% | 42.8 | 14/100⭐ |
| Industrials | -1.3% | -0.9% | -9.7% | 30.4 | 14/100⭐ |
| Technology | -2.6% | -1.8% | -6.3% | 41.5 | 12/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-27.